Zyprexa targeted in St. Clair County
-TheSt.ClairRecord
10/14/2009 - Eli Lilly is being sued by an Illinois woman and an unknown number of plaintiffs who claim either they or their children developed a number of conditions ranging from diabetes to weight gain after taking the antipsychotic medication Zyprexa. More>>>

Idaho to get $13 million over mental-health drug Zyprexa: Settlement is second-largest under state's Consumer Protection Act
-Trading Markets
10/14/2009 - The Idaho attorney general's office alleged that drug manufacturer Eli Lilly marketed its top-selling drug Zyprexa deceptively and failed to warn health-care providers that patients could suffer side effects such as weight gain and diabetes More>>>

Eli Lilly says it will settle SC suit
-GoUpstate
10/08/2009 - A spokeswoman for a major drug manufacturer said Wednesday that a "tentative settlement" to a lawsuit filed by the state of South Carolina has been reached. The Attorney General's office, however, said a confirmed agreement between the state and Eli Lilly & Co. does not exist. More>>>

Lilly Reaches Zyprexa Agreement With Seven States
-Bloomberg
09/22/2009 - Eli Lilly & Co. agreed to settle, on confidential terms, lawsuits filed by seven states alleging the company improperly marketed its antipsychotic drug Zyprexa, a court-appointed official said. More>>>

Eli Lilly paid doctors to write Zyprexa prescriptions?
-Justice News Flash
09/18/2009 - South Carolina government lawyers introduced damaging evidence in a court hearing in a lawsuit against the drug company, Eli Lilly. Pharmaceutical sales representatives’ notes reveal South Carolina doctors were paid for prescribing Zyprexa, a now highly debated antipsychotic, to patients. More>>>

Lilly in dock over improper marketing
-PharmaTimes
09/11/2009 - Eli Lilly is the new drug giant to be raked over hot coals for improper marketing of its drugs. Sales notes were made public for the first time in a South Carolina court this week allegedly detailing that Eli Lilly provided a number of incentives to doctors, such as being paid to take part in speakers’ programmes, in return for prescribing the company’s antipsychotic Zyprexa (olanzapine). More>>>

Judge wants 'global settlement' of remaining AG Zyprexa suits
-Legal Newsline
09/03/2009 - U.S. District Judge Jack Weinstein recently continued his push to have all state actions filed against Eli Lilly & Co. over its prescription antipsychotic Zyprexa settled. More>>>

Pfizer to pay $2.3 billion, agrees to criminal plea
-Reuters
09/03/2009 - Pfizer Inc agreed on Wednesday to plead guilty to a U.S. criminal charge relating to promotion of its now-withdrawn Bextra pain medicine and will pay a record $2.3 billion to settle allegations it improperly marketed 13 medicines. More>>>

W.Va.'s Zyprexa settlement unsealed
-Legal Newsline
08/25/2009 - Pharmaceuticals maker Eli Lilly & Co. has agreed to pay $22.5 million to settle a lawsuit brought by West Virginia Attorney General Darrell McGraw over its prescription anti-psychotic Zyprexa. More>>>

Lilly to Pay $22.5 Million to Settle Zyprexa Suit
-Bloomberg
08/21/2009 - Eli Lilly & Co. will pay $22.5 million to settle a lawsuit brought by the state of West Virginia claiming the company improperly marketed its antipsychotic drug Zyprexa. More>>>

Three states have Sept. date for Zyprexa arguments
-Legal Newsline
08/20/2009 - Three state attorneys general who still have Zyprexa lawsuits against Eli Lilly & Co. will have their attorneys in Brooklyn federal court next month to argue their cases and possibly talk settlement. More>>>

Eli Lilly Zyprexa Risk Side Effects
-OPENPRESS
08/17/2009 - Zyprexa's many drug interactions, side effects,and effectiveness could not be detected when the drug was FDA approved. They were found only after the drug have been used by millions of people and for a long time.
Eli Lilly has received the largest criminal fine ever against a drug company over their Zyprexa cash cow,add it all up comes to $4.6 billion, in Zyprexa settlements,fines,litigation. More>>>

Area doctors paid thousands by Eli Lilly
-TheRoanokeTimes
08/13/2009 - The drug company Eli Lilly and Co. pumped $60,562.50 into the pockets of Roanoke doctors and other health care providers during the first three months of the year. More>>>

Lilly nears another Zyprexa settlement
-FiercePharma
07/24/2009 - Eli Lilly is close to settling another slate of Zyprexa marketing cases. According to the company's quarterly report, it's in "advanced discussions" with attorneys general investigating the company for off-label promotions of the antipsychotic drug. More>>>

Zyprexa user claims diabetes in suit against Eli Lilly
-St.ClaireRecord
07/14/2009 - Eli Lilly is being sued by an Illinois man who claims he developed diabetes after taking the antipsychotic medication Zyprexa. Caleb Russell says he began taking drug, which is used to treat schizophrenia and acute manic episodes associated with Bipolar I disorder, at the age of 13 in 2003. A short time after his ingestion of the medication, Russell developed diabetes, according to the complaint filed June 30 in St. Clair County Circuit Court. More>>>

R.I. to share in penalty
-ProvidenceJournal
06/18/2009 - Rhode Island, 35 other states, the District of Columbia and the federal government have reached an agreement with Eli Lilly and Co. to settle allegations that that drugmaker engaged in a six-year “off-label” marketing campaign that improperly promoted the anti-psychotic drug Zyprexa. More>>>

Kentucky settles with Eli Lilly over Zyprexa marketing
-BusinessFirst Louisville
06/18/2009 - Kentucky Attorney General Jack Conway has settled with drug maker Eli Lilly and Co. over allegations of improper marketing of its Zyprexa antipsychotic drug. More>>>

Eli Lilly To Pay Millions After 'Deceptive' Marketing Practices
-KETV
06/18/2009 - Pharmaceutical company Eli Lilly was forced to pay more than $1.7 million to Nebraska on allegations that it improperly marketed an antipsychotic drug. More>>>

Colorado receives $2.6M share of Lilly settlement over Zyprexa
-DenverBusinessJournal
06/18/2009 - Colorado has now received its $2.6 million share of a multistate settlement with Eli Lilly and Co. over allegations that the drugmaker improperly promoted the anti-psychotic drug, Zyprexa, state Attorney General John Suthers announced Friday. More>>>

Killing for Fun and Profit
-OpEdNews
06/17/2009 - Bloomberg reports a U.S. District Court Judge has allowed law suits to move forward against Eli Lilly, the drug company is accused of selling and encouraging physicians to prescribe the drug Zyprexa for uses never proven or approved by the FDA. More>>>

Eli Lilly and Zyprexa Under the Spotlight
-PsychCentral
06/16/2009 - Eli Lilly & Co.’s atypical antipsychotic medication, Zyprexa, was not only marketed to doctors for an unapproved, off-label use — the treatment of dementia in elderly patients — but it was done despite Lilly’s access and knowledge of at least seven studies that showed the drug was apparently ineffective for the treatment of dementia. More>>>

Zyprexa suit highlights CVS links to Lilly
Unit was paid to pitch drug to health insurers
-Boston.com
06/16/2009 - A unit of CVS Caremark Corp. used its access to doctors to market Eli Lilly & Co.'s Zyprexa antipsychotic while it was under contract to bargain with the drug maker on behalf of health insurers, internal Lilly files disclosed in a multibillion-dollar lawsuit by insurers show. More>>>

Lilly ‘Ghostwrote’ Articles to Market Zyprexa, Case Files Show
-Bloomberg
06/12/2009 - Eli Lilly & Co. officials wrote medical journal studies about the antipsychotic Zyprexa and then asked doctors to put their names on the articles, a practice called “ghostwriting,” according to unsealed company files. More>>>

Eli Lilly Promoted Zyprexa for Patients Who Were Badly Dressed
-BNETPharm
06/05/2009 - When Eli Lilly launched Zyprexa, its drug sales reps campaigned for doctors to prescribe the antipsychotic off-label to patients who appeared to be depressed because their clothes were “drab” or “disheveled,” according to a study in Social Science & Medicine. More>>>

Eli Lilly Stalling Zyprexa Claims
-OPENPRESS
06/04/2009 - Lilly's (NOW up to $4.6 billion) Zyprexa settlement payout is being stonewalled. 8 Lilly employees who are supposed 'whistle-blowers' are getting $ 10 million each the real victims like me are being ignored. More>>>

Eli Lilly Zyprexa Claims Being Stonewalled
-TheOpenPress
04/12/2009 - Eli Lilly, the Indy-based pharmaceutical company pleads guilty to promoting Zyprexa for unapproved uses and is slapped with $1.4 billion criminal fine, the largest ever placed on a U.S. company. It's the largest pharma-fraud-whistleblower case in US history. More>>>

Lilly May Spend $2 Billion More on Zyprexa Lawsuits|
-Bloomberg
01/30/2009- Eli Lilly & Co., after agreeing to spend more than $2.6 billion to settle government and individual claims over its antipsychotic Zyprexa, still faces lawsuits over the drug that might cost the company another $2 billion. More>>>

Eli Lilly Admits Zyprexa Guilt
-NewsInferno
01/24/2009- Eli Lilly finally admitted some wrongdoing in how it marketed Zyprexa. Lilly also agreed to pay over $1.4 billion in settlements, but did not officially admit its guilt in the civil investigation, reported Forbes. Zyprexa has been linked to serious side effects including diabetes, hyperglycemia, and other blood sugar disorders. More>>>

Lilly Loses Appeal to Limit Damages in Zyprexa Suit
-Bloomberg
11/27/2008- Eli Lilly & Co. lost its bid at Ontario's highest court to limit potential damages in a lawsuit filed by Canadian patients who claimed they developed diabetes after using its Zyprexa schizophrenia drug. More>>>

Judge Unseals Confidential Zyprexa Documents
-InjuryBoard.com
09/12/2008- A federal district court judge granted a motion to unseal hundreds of confidential documents about Zyprexa, Eli Lilly’s popular antipsychotic drug. More>>>

Judge OKs Zyprexa Class Action, Unseals Documents
-NewsInferno.com
09/10/2008- A federal judge has granted class action status to a Zyprexa lawsuit that claimed Eli Lilly hid the drug’s serious side effects. The decision by Judge Jack B. Weinstein of Federal District Court in Brooklyn also unseals confidential documents relating to the antipsychotic medication. More>>>

Lilly Faces Zyprexa Class Action By 3rd-Party Payors
-Pharmalot
09/07/2008- Insurers, labor unions and pension funds can proceed with a class-action suit that claims they were overcharged by the drugmaker, which allegedly withheld information and disseminated misinformation about the safety and effectiveness of the antipsychotic, according to a hefty, 295-page opinion by US District Court Judge Jack Weinstein. His decision comes two months after he urged Lilly to settle. More>>>

Former FDA Official Testifies that Eli Lilly Lied about Drug Side Effects
-Natural News
09/07/2008-Pharmaceutical company Eli Lilly concealed the risks of its schizophrenia drug Zyprexa from U.S. regulators in order to increase its profits, a former FDA official has testified in Alaska court. More>>>

Antipsychotics more than triple stroke risk in dementia
-Pharma Times
09/03/2008- A new analysis of patient records in the UK confirms that prescribing antipsychotics to people with dementia is not only ethically dubious but carries a serious risk of stroke, particularly when the newer atypical antipsychotics are used. More>>>

Antipsychotic Drugs Boost Stroke Risk
-Forbes.com
08/29/2008- All antipsychotic drugs can increase the risk of stroke, but the risk is greatest among older patients with dementia, British researchers report. More>>>

Lilly May Need Stronger U.S. Warning on Zyprexa Label (Update4)
-Bloomberg
07/30/2008- Eli Lilly & Co.'s current label warning on health risks linked to its antipsychotic Zyprexa may not be strong enough, according to court documents. More>>>

Unwanted consequences of antipsychotic drugs
-The Philadelphia Inquirer
05/31/2008- Antipsychotic drugs are often prescribed to treat agitation and other symptoms of dementia, but a new study suggests they may have unwanted consequences. More>>>

Eli Lilly STALLING on ZYPREXA Payout
-World Forum

05/02/2008 - Lilly's credibility over their continuous PR on how they are going to pay out $1.2 billion in Zyprexa damages Many claimants are being stonewalled. More>>>

Anti-Psychotic Drugs (Zyprexa) Change Metabolism

-American Psysiological Society

04/20/2008 - “Based on these findings we concluded that male rats treated with olanzapine experienced an early disruption of energy metabolism. More>>>

Lechleiter inspired by Lilly's legacy

-Indy Star

04/07/2008 - Eli Lilly and Co.'s storied history was on full display last week as Sidney Taurel, a career Lilly man, retired as chief executive and was replaced by John Lechleiter, another career Lilly man. More>>>

Eli Lilly ZYPREXA Chronicles

-Indy Star

04/06/2008 - Some fast facts on the Zyprexa controversy chronicled by a patient user. More>>>

Elli Lilly Zyprexa Rico Lawsuit

-PR-Net

04/04/2008 - Attorney General Richard Blumenthal sues Eli Lilly and Company, Inc. for illegally marketing its anti psychotic drug Zyprexa for unapproved uses, and concealing the drug's serious side effects, for more than a decade. More>>>

New Anti psychotics No Better For First Episodes

-Pharmalot

03/28/2008 - The so-called atypical's - including Abilify, Risperdal, Zyprexa, Seroquel and Geodon - have been hailed as more effective and easier to tolerate than the older and cheaper kind such as Haldol, which cause tremors and rigid muscles. But the new generation are no better at treating a first episode of schizophrenia, according to a study in The Lancet. More>>>

Eli Lilly Settling Zyprexa Lawsuit

-FDA News

03/28/2008 - Eli Lilly has agreed to pay Alaska $15 million to settle a lawsuit alleging the company made deceptive claims about Zyprexa, concealed the drug’s side effects and marketed it off-label for Medicaid recipients. More>>>

Alaska Suit Against Lilly Is Settled

-NY Times

03/27/2008 - The prospect of a pending Supreme Court case that could sweep away many lawsuits against drug companies loomed over Alaska’s decision to settle the state’s suit against Eli Lilly over the schizophrenia drug Zyprexa, lawyers for Lilly and the state said Wednesday. More>>>

Concerns About Supreme Court Case on Product Liability in State Courts Prompt Alaska To Settle Medicaid Lawsuit

-Kaiser Network

03/27/2008 - The $15 million settlement this week of a lawsuit filed by the state of Alaska against Eli Lilly over allegations that the company concealed data about the side effects of the anti psychotic Zyprexa More>>>

Lilly Settles Alaska Suit Over Zyprexa

-NY Times

03/26/2008 - Eli Lilly has agreed to pay $15 million to the state of Alaska to settle a lawsuit claiming that the company’s schizophrenia drug Zyprexa caused patients to develop diabetes, Lilly and the state said Wednesday morning. More>>>

Lilly settles Zyprexa case with Alaska for $15 mln

-Reuters

03/26/2008 - Eli Lilly and Co on Wednesday said it agreed to pay $15 million to settle a lawsuit by the state of Alaska accusing it of concealing possible side effects from Zyprexa, its widely used schizophrenia medicine. More>>>

Lilly agrees to $15 million payout to settle Alaskan Zyprexa case

-PharmaTimes

03/26/2008 - US drug giant Eli Lilly has agreed to pay the state of Alaska $15 million to settle claims that its Medicaid program was not adequately warned over potential side effects from the use of its anti psychotic Zyprexa. More>>>

Why Drug Lawsuits are Necessary: FDA “isn’t capable of policing” drug safety, says Alaska Judge

-Tort Deform

03/25/2008 - The state of Alaska is suing Eli Lilly (NYSE:LLY) for failing to disclose health risks (like diabetes and weight gain) allegedly associated with Lilly’s hugely profitable “atypical anti psychotic” drug Zyprexa. More>>>

Zyprexa: Balancing Serious Side Effects With Serious Illness

-Wall Street Journal

03/25/2008 - Lawyers for the state of Alaska have spent weeks arguing in an Anchorage courthouse that Eli Lilly hid the dangers of its anti psychotic drug Zyprexa — a claim Lilly denies. More>>>

Former Biotech CEO Indicted on Fraud Charges

-Wall Street Journal

03/19/2008 - The feds have indicted a former biotech CEO, arguing that he committed criminal acts when he promoted a drug for uses that hadn’t been approved by the FDA. More>>>

Lilly Zyprexa-Claim Losses May Climb to $1.83 a Share

-Bloomberg

03/18/2008 - An adverse jury decision in Alaska may be the first step in tripling to more than $3 billion Eli Lilly & Co.'s costs of resolving lawsuits over Zyprexa, which generates more than one-fourth of the company's revenue. More>>>

API patients on Zyprexa got diabetes, official says

-Anchorage Daily News

03/13/2008 - Patients taking the anti-psychotic drug Zyprexa needlessly developed diabetes because doctors didn't have all the information about risks, the medical director of Alaska's only public mental hospital said in court Wednesday. More>>>

Eli Lilly Denies Corrupt Practices On Zyprexa

-CNN

03/12/2008 - Eli Lilly & Co. (LLY) said it "strongly disagrees" with statements made by Connecticut Attorney General Richard Blumenthal Tuesday regarding the company's marketing of anti psychotic drug Zyprexa. More>>>

Lilly accused of "sick marketing mind set" in new Zyprexa lawsuit

-PharmaTimes

03/12/2008 - Connecticut has become the latest US state to sue Eli Lilly after claiming that the firm marketed the anti psychotic Zyprexa for unapproved off-label uses,and hid side effects such as weight gain and diabetes. More>>>

Connecticut Sues Eli Lilly Over Zyprexa

-eCanadaNow

03/12/2008 - Washington (eCanadaNow) - Connecticut has joined the list of states who have filed lawsuits against drug manufacturer Eli Lilly, over their Zyprexa drug. More>>>

Connecticut Sues Eli Lilly Over Zyprexa

-Wall Street Journal

03/11/2008 - Connecticut’s Attorney General Richard Blumenthal is suing Eli Lilly over the marketing of its anti psychotic drug Zyprexa, the AP reports. He ought to take a number — at least nine other states are suing the company for similar reasons. And federal prosecutors are also on the case, reportedly negotiating a big settlement with the company. More>>>

Anti psychotic meds may raise blood sugar
-Blog.wsj.com
03/02/2008 - Even as Eli Lilly’s lawyers are getting ready to defend a Zyprexa case in Alaska, the company’s got bad news from the FDA, four time zones away. The agency refused to approve the company’s application for a long-acting form of the anti-psychotic drug the company said this morning. More>>>>

FDA Doesn't Approve A Form of Lilly's Zyprexa
-Wall Street Journal Online
02/29/2008 - The Food and Drug Administration declined to approve a long-acting, injectable form of Eli Lilly & Co.'s top-selling drug Zyprexa, the company said. More>>>

FDA rebuffs long-acting Zyprexa

-Indianapolis Business Journal
02/28/2008 - Eli Lilly and Co. has been rejected in its attempt to win approval for a long-acting, injectible version of its best-selling drug, Zyprexa. More>>>

Drug Company 'Eli Lilly' In Advanced Settlement Talks with Federal Investigators
-Tech News
02/27/2008 - Schizophrenia is a mental illness that affects over 2 million people in the U.S. Symptoms include severely impaired thinking, emotions, and behaviors. Typically, its onset is between the ages of 16 and 25 and about $70 billion is spent each year to treat the disease. More>>>>

Eli Lilly in Shareholder Cross Hairs
-FDA News

02/11/2008 - While Eli Lilly's Zyprexa troubles with the federal government may be coming to an end, the company faces new legal problems with a recent lawsuit filed by two of the company's shareholders. More>>>>

Long-Acting Zyprexa Works, But Has Sedation Risk, FDA Says
-Wall Street Journal
02/04/2008 -The Food and Drug Administration said Monday that a long-acting, injectable form of Eli Lilly & Co.'s top-selling drug Zyprexa was effective at treating schizophrenia but caused "profound sedation" in certain patients. More>>>>

Lilly subpoenaed on Zyprexa marketing
-LA Times

01/31/2008 - Eli Lilly & Co. said Wednesday that it received a subpoena in November from a U.S. grand jury in Pennsylvania seeking documents involving the marketing of the company's best selling drug, the anti psychotic Zyprexa. More>>>>

Lilly reportedly in talks with feds Newspaper: $1B payment
-Indianapolis Star
01/31/2008 - Eli Lilly and Co. could pay more than $1 billion to settle a criminal and civil investigation into the marketing of its anti psychotic drug Zyprexa, according to The New York Times, citing anonymous sources involved in the probe. More>>>>

Lilly Is in Talks to Settle Zyprexa Allegations
-Wall Street Journal

01/31/2008 - Eli Lilly & Co. is in advanced settlement talks with federal investigators regarding the company's marketing of anti psychotic drug Zyprexa, after a grand jury subpoena late last year raised the prospect that the company could be indicted. More>>>>

Discovery Limited in Zyprexa Case

-Indianapolis Star
12/07/2004 - A federal judge has told Eli Lilly and Co. to be ready for trial within a year to defend its star drug Zyprexa against charges in federal court that the drug causes diabetes and related problems.More>>>

Lilly Adds Weapon in Zyprexa Suits

-Indianapolis Star
11/07/2004 - Eli Lilly Co. is using a new legal tactic to stall the filing of potentially hundreds of new lawsuits over its best-selling drug Zyprexa.More>>>

Lilly Acts to Counter Attack Ads

-Indianapolis Star
10/14/2004 - Eli Lilly and Co. said it is concerned that lawyers are scaring some patients from using the anti-psychotic Zyprexa by running advertisements seeking clients who feel they have been harmed by the drug.More>>>

If you or a loved one have experienced Zyprexa side effects you may be entitled to compensation. Contact the Zyprexa attorneys of Ennis & Ennis today for a free confidential case evaluation. Our on staff nurse and lawyers are standing by to answer any questions you may have regarding Zyprexa side effects, a possible Zyprexa class action lawsuit, or any other type of Zyprexa litigation.